These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The second generation oral sulfonylureas: glyburide and glipizide. Kuhn T. Am Pharm; 1988 Oct 23; NS28(10):55-61. PubMed ID: 3143256 [No Abstract] [Full Text] [Related]
9. The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis. Pantalone KM, Kattan MW, Yu C, Wells BJ, Arrigain S, Jain A, Atreja A, Zimmerman RS. Diabetes Care; 2010 Jun 23; 33(6):1224-9. PubMed ID: 20215447 [Abstract] [Full Text] [Related]
10. [Glipizide: a 2d generation sulfonamide and new antidiabetic]. Deuil R. Nouv Presse Med; 1975 Feb 15; 4(7):500-1. PubMed ID: 1093131 [No Abstract] [Full Text] [Related]
11. [Glipizide a new oral antidiabetic agent (comprehensive review)]. Brunová E. Vnitr Lek; 1976 Jun 15; 22(6):595-9. PubMed ID: 820071 [No Abstract] [Full Text] [Related]
13. Diabetes control in the elderly: a randomized, comparative study of glyburide versus glipizide in non-insulin-dependent diabetes mellitus. Rosenstock J, Corrao PJ, Goldberg RB, Kilo C. Clin Ther; 1993 Jun 15; 15(6):1031-40. PubMed ID: 8111800 [Abstract] [Full Text] [Related]
14. Multicenter comparison of glyburide and glipizide in the treatment of non-insulin-dependent diabetes mellitus. Kilo C. Clin Ther; 1988 Jun 15; 10(3):294-302. PubMed ID: 3152586 [Abstract] [Full Text] [Related]
19. The new oral antidiabetic drugs. Moss JM, Delawter DE. Am Fam Physician; 1984 Nov 15; 30(5):119-21. PubMed ID: 6437197 [No Abstract] [Full Text] [Related]